Aquestive Therapeutics Inc. (AQST) NASDAQ

$4.11 (0.40) (-8.78%)

Market Cap: $300.90M

As of 04/19/24 04:00 PM EDT. Market closed.

(AQST)

Aquestive Therapeutics Inc. (AQST)
NASDAQ

$4.11
(0.40) (-8.78%)

Market Cap: $300.90M

As of 04/19/24 04:00 PM EDT. Market closed.

Add to Portfolio

aquestive therapeutics is a specialty pharmaceutical company that advances and commercializes medicines to solve critical healthcare problems and meaningfully improve people’s lives. our team asks questions and identifies issues others have not, and builds solutions that empower patients and their caregivers with better ways to manage complex diseases. our initial focus, supported by our ... read more

aquestive therapeutics is a specialty pharmaceutical company that advances and commercializes medicines to solve critical healthcare problems and meaningfully improve people’s lives. our team asks questions and identifies issues others have not, and builds solutions that empower patients and their caregivers with better ways to manage complex diseases. our initial focus, supported by our current approved products and late stage pipeline, is to address immediate cns challenges. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Medicinal and Botanical Manufacturing
CEO Compensation (Base)
$450,000
CEO Compensation (Total)
$8.01M
URL
Address
.
Sector
Manufacturing
Industry
Medicinal and Botanical Manufacturing
Full Time Employees
111
CEO Compensation (Base)
$450,000
CEO Compensation (Total)
$8.01M
Address
.
PRICE CHART FOR AQUESTIVE THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$4.34
Previous Close
$4.50
Days Range
$4.05 - $4.54
52 week range
$1.15 - $6.23
Volume
2,340,719
Avg. Volume (30 days)
2,756,908
Market Cap
$300.90M
Dividend Yield
-
P/E
(38.23)
Shares Outstanding
73,301,201
Open
$4.34
Previous Close
$4.50
Days Range
$4.05 - $4.54
52 week range
$1.15 - $6.23
Volume
2,340,719
Avg. Volume (30 days)
2,756,908
Market Cap
$300.90M
Dividend Yield
-
P/E
(38.23)
Shares Outstanding
73,301,201
FINANCIAL STATEMENTS FOR AQUESTIVE THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR AQUESTIVE THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Schobel Alexander MarkChief Innovation/Tech OfficerMar 15, 2024 Sale$6.0050,000300,000984,476Mar 19, 2024, 02:30 PM
Barber DanielPresident and CEOMar 09, 2024 Option Exercise$4.8837,938185,137845,364Mar 12, 2024, 01:47 PM
Boyd Peter E.See RemarkMar 09, 2024 Option Exercise$4.888,37040,846237,628Mar 12, 2024, 01:47 PM
BRAENDER LORI JSVP, General CounselMar 09, 2024 Option Exercise$4.8810,53051,386313,231Mar 12, 2024, 01:47 PM
TOTH A ERNEST JRSVP, Chief Financial OfficerMar 09, 2024 Option Exercise$4.8811,70557,120248,295Mar 12, 2024, 01:47 PM
Wargacki StephenSVP, Research & DevelopmentMar 10, 2024 Option Exercise$4.881,6878,233257,963Mar 12, 2024, 01:46 PM
Wargacki StephenSVP, Research & DevelopmentMar 09, 2024 Option Exercise$4.8811,26954,993259,650Mar 12, 2024, 01:46 PM
Jung CassieSVP, OperationsMar 10, 2024 Option Exercise$4.881,1325,524237,754Mar 12, 2024, 01:46 PM
Jung CassieSVP, OperationsMar 09, 2024 Option Exercise$4.888,30040,504238,886Mar 12, 2024, 01:46 PM
Schobel Alexander MarkChief Innovation/Tech OfficerMar 09, 2024 Option Exercise$4.885,89528,7681,034,476Mar 12, 2024, 01:45 PM
Schobel Alexander MarkChief Innovation/Tech OfficerMar 08, 2024 Sale$5.1925,000129,6851,040,371Mar 12, 2024, 01:45 PM
Wargacki StephenSVP, Research & DevelopmentMar 10, 2023 Option Exercise$0.791,9811,572158,419Mar 11, 2024, 10:34 AM
Boyd Peter E.SVP-Bus. Process & Info. Tech.Jun 14, 2022 Buy$0.815,0004,05059,532Jun 15, 2022, 10:24 AM
Barber DanielChief Executive OfficerJun 08, 2022 Buy$0.9691,74388,073193,702Jun 10, 2022, 05:27 PM
Schobel Alexander MarkChief Innovation/Tech OfficerJun 08, 2022 Buy$0.9645,87144,036882,871Jun 10, 2022, 05:26 PM
Boyd Peter E.SVP-Bus. Process & Info. Tech.Jun 08, 2022 Buy$0.962,2932,20154,532Jun 10, 2022, 05:26 PM
BRAENDER LORI JGeneral CounselJun 08, 2022 Buy$0.9613,76113,21138,761Jun 10, 2022, 05:26 PM
Schobel Alexander MarkChief Innovation/Tech OfficerFeb 10, 2021 Sale$6.7523,460158,355837,000Feb 10, 2021, 08:17 PM
Schobel Alexander MarkChief Innovation/Tech OfficerFeb 09, 2021 Sale$6.7511,54077,895860,460Feb 10, 2021, 08:17 PM
Schobel Alexander MarkChief Innovation/Tech OfficerFeb 08, 2021 Sale$6.5040,792265,148872,000Feb 09, 2021, 04:00 PM
Maxwell John T.SVP-Chief Financial OfficerAug 18, 2020 Sale$8.003,00024,000150,614Aug 19, 2020, 08:55 AM
Kendall Keith JCEO and PresidentJun 30, 2020 Option Exercise$4.86148719639,149Jul 02, 2020, 12:00 AM
Schobel Alexander MarkChief Innovation/Tech OfficerJun 30, 2020 Option Exercise$4.8694457912,792Jul 02, 2020, 12:00 AM
Kendall Keith JCEO and PresidentJun 04, 2020 Sale$5.1150,000255,310638,964Jun 05, 2020, 04:05 PM
Schobel Alexander MarkChief Innovation/Tech OfficerMay 31, 2020 Option Exercise$4.874,13220,123912,553Jun 02, 2020, 05:14 PM
Kendall Keith JCEO and PresidentMay 31, 2020 Option Exercise$4.876,49231,616688,964Jun 02, 2020, 05:13 PM
Schobel Alexander MarkChief Innovation/Tech OfficerMay 08, 2020 Sale$5.0040,000200,000902,113May 11, 2020, 04:15 PM
Schobel Alexander MarkChief Innovation/Tech OfficerApr 27, 2020 Sale$4.0040,000160,000942,113May 04, 2020, 04:05 PM
Schobel Alexander MarkChief Innovation/Tech OfficerApr 14, 2020 Sale$3.7040,000148,000982,113May 04, 2020, 04:05 PM
Schobel Alexander MarkChief Innovation/Tech OfficerApr 29, 2020 Sale$4.5040,000180,0001,022,113May 01, 2020, 04:05 PM
Kendall Keith JCEO and PresidentMar 31, 2020 Option Exercise$2.1999217680,884Apr 02, 2020, 04:16 PM
Schobel Alexander MarkChief Innovation/Tech OfficerMar 31, 2020 Option Exercise$2.19972121,062,113Apr 02, 2020, 04:16 PM
BRAENDER LORI JSVP, General CounselMar 16, 2020 Buy$1.5414,00021,62425,000Mar 18, 2020, 04:45 PM
Boyd Peter E.SVP-Bus. Process & Info. Tech.Mar 16, 2020 Buy$1.502,0003,00052,239Mar 18, 2020, 04:45 PM
Schobel Alexander MarkChief Innovation/Tech OfficerFeb 29, 2020 Option Exercise$3.735,06618,8961,061,881Mar 03, 2020, 07:38 PM
Kendall Keith JCEO and PresidentFeb 29, 2020 Option Exercise$3.734,72917,639680,654Mar 03, 2020, 07:37 PM
Kendall Keith JCEO and PresidentDec 31, 2019 Option Exercise$5.82149867670,811Feb 26, 2020, 04:20 PM
Schobel Alexander MarkChief Innovation/Tech OfficerDec 31, 2019 Option Exercise$5.821478561,052,375Feb 26, 2020, 04:20 PM
Kendall Keith JCEO and PresidentNov 30, 2019 Option Exercise$7.796,59751,391670,631Feb 26, 2020, 04:05 PM
Schobel Alexander MarkChief Innovation/Tech OfficerNov 30, 2019 Option Exercise$7.796,54450,9781,052,193Feb 26, 2020, 04:05 PM
Schobel Alexander MarkChief Innovation/Tech OfficerDec 31, 2019 Option Exercise$5.823291,9151,044,165Jan 02, 2020, 04:15 PM
Kendall Keith JCEO and PresidentDec 31, 2019 Option Exercise$5.823291,915662,656Jan 02, 2020, 02:04 PM
Kendall Keith JCEO and PresidentNov 30, 2019 Option Exercise$7.7914,572113,516662,656Dec 02, 2019, 04:56 PM
Schobel Alexander MarkChief Innovation/Tech OfficerNov 30, 2019 Option Exercise$7.7914,572113,5161,044,165Dec 02, 2019, 04:56 PM
Schobel Alexander MarkChief Innovation/Tech OfficerSep 30, 2019 Option Exercise$3.181454611,044,165Oct 02, 2019, 04:33 PM
Kendall Keith JCEO and PresidentSep 30, 2019 Option Exercise$3.18150477662,656Oct 02, 2019, 04:33 PM
Kendall Keith JCEO and PresidentAug 31, 2019 Option Exercise$3.806,67625,369662,477Sep 03, 2019, 06:09 PM
Schobel Alexander MarkChief Innovation/Tech OfficerAug 31, 2019 Option Exercise$3.806,46024,5481,043,981Sep 03, 2019, 06:09 PM
Barber DanielSVP-Chief Operating OfficerAug 27, 2019 Buy$3.992,0007,980101,959Aug 27, 2019, 09:49 PM
Scibetta James SDirectorAug 21, 2019 Buy$3.819003,42931,635Aug 22, 2019, 04:30 PM
Scibetta James SDirectorAug 20, 2019 Buy$3.8011,31043,00130,735Aug 22, 2019, 04:30 PM
Scibetta James SDirectorAug 19, 2019 Buy$3.7710,76140,54719,425Aug 22, 2019, 04:30 PM
Kendall Keith JCEO and PresidentAug 14, 2019 Buy$3.672,0007,347654,581Aug 20, 2019, 04:30 PM
Kendall Keith JCEO and PresidentAug 13, 2019 Buy$4.051,0004,045652,581Aug 20, 2019, 04:30 PM
Kendall Keith JCEO and PresidentAug 09, 2019 Buy$3.925,00019,595651,581Aug 20, 2019, 04:30 PM
Wood TheresaSVP-HR and Org. DevelopmentAug 09, 2019 Buy$3.991,0003,99080,765Aug 13, 2019, 04:30 PM
BRAENDER LORI JSVP, General CounselAug 09, 2019 Buy$4.0710,00040,74711,000Aug 13, 2019, 04:30 PM
Boyd Peter E.SVP-Bus. Process & Info. Tech.Aug 12, 2019 Buy$3.816002,28650,239Aug 13, 2019, 04:30 PM
Kendall Keith JCEO and PresidentJun 30, 2019 Option Exercise$4.20154647646,581Jul 02, 2019, 12:00 AM
Schobel Alexander MarkChief Innovation/Tech OfficerJun 30, 2019 Option Exercise$4.201496261,035,869Jul 02, 2019, 12:00 AM
Schobel Alexander MarkChief Innovation/Tech OfficerMay 31, 2019 Option Exercise$3.726,59124,5191,035,689Jun 03, 2019, 04:15 PM
Kendall Keith JCEO and PresidentMay 31, 2019 Option Exercise$3.726,78025,222646,406Jun 03, 2019, 04:15 PM
Schobel Alexander MarkChief Innovation/Tech OfficerMar 31, 2019 Option Exercise$6.912631,8171,027,708Apr 01, 2019, 04:40 PM
Kendall Keith JCEO and PresidentMar 31, 2019 Option Exercise$6.912631,817638,614Apr 01, 2019, 04:40 PM
Kendall Keith JCEO and PresidentFeb 28, 2019 Option Exercise$8.054,72538,036638,548Mar 01, 2019, 05:24 PM
Schobel Alexander MarkChief Innovation/Tech OfficerFeb 28, 2019 Option Exercise$8.056,72154,1041,027,642Mar 01, 2019, 05:23 PM
Schobel Alexander MarkChief Innovation/Tech OfficerDec 31, 2018 Option Exercise$6.301621,0211,019,791Jan 03, 2019, 05:30 PM
Kendall Keith JCEO and PresidentDec 31, 2018 Option Exercise$6.301621,021628,701Jan 03, 2019, 05:23 PM
Schobel Alexander MarkChief Innovation/Tech OfficerDec 10, 2018 Buy$7.781,0007,7801,019,624Dec 11, 2018, 05:41 PM
Schobel Alexander MarkChief Innovation/Tech OfficerDec 06, 2018 Buy$8.692,00017,3801,018,624Dec 10, 2018, 05:47 PM
Barber DanielSVP-Chief Strategy/Dev OfficerDec 10, 2018 Buy$8.001,0008,00099,959Dec 10, 2018, 05:46 PM
Maxwell John T.SVP-Chief Financial OfficerDec 06, 2018 Buy$8.875,00044,350153,614Dec 07, 2018, 04:27 PM
Schobel Alexander MarkChief Innovation/Tech OfficerNov 30, 2018 Option Exercise$8.597,17761,6501,016,624Dec 04, 2018, 04:05 PM
Kendall Keith JCEO and PresidentNov 30, 2018 Option Exercise$8.597,17761,650628,534Dec 04, 2018, 04:02 PM
Marshall Ken W.Commercial LeaderNov 21, 2018 Buy$10.151,44514,6671,445Dec 03, 2018, 04:01 PM
BRAENDER LORI JGeneral CounselNov 27, 2018 Buy$10.571,00010,5701,000Nov 29, 2018, 04:01 PM
Kendall Keith JCEO and PresidentNov 27, 2018 Buy$9.871,0009,870621,139Nov 28, 2018, 04:01 PM
Wood TheresaSVP-HR and Org. DevelopmentNov 26, 2018 Buy$10.345005,17079,765Nov 26, 2018, 02:53 PM
Schobel Alexander MarkChief Innovation/Tech OfficerNov 21, 2018 Buy$10.251,00010,2501,009,229Nov 26, 2018, 01:43 PM
Maxwell John T.SVP-Chief Financial OfficerNov 21, 2018 Buy$9.8010,00098,000148,614Nov 26, 2018, 01:39 PM
Kendall Keith JCEO and PresidentNov 23, 2018 Buy$9.901,95019,305620,139Nov 26, 2018, 01:38 PM
Kendall Keith JCEO and PresidentNov 21, 2018 Buy$10.176,00061,020618,189Nov 26, 2018, 01:38 PM
Boyd Peter E.SVP-Operations/Value DeliveryNov 21, 2018 Buy$9.982001,99649,639Nov 26, 2018, 01:35 PM
Kendall Keith JCEO and PresidentSep 30, 2018 Option Exercise$17.511622,8371,008,229Oct 02, 2018, 04:38 PM
Schobel Alexander MarkChief Innovation/Tech OfficerSep 30, 2018 Option Exercise$17.511622,8371,008,229Oct 02, 2018, 12:00 AM
Kendall Keith JCEO and PresidentAug 31, 2018 Option Exercise$18.016,510117,2451,008,062Sep 05, 2018, 05:41 PM
Schobel Alexander MarkChief Innovation/Tech OfficerAug 31, 2018 Option Exercise$18.016,510117,2451,008,062Sep 05, 2018, 05:39 PM
BRATTON DOUGLAS KDirectorJul 24, 2018 Buy$15.00165,0002,475,000165,000Jul 26, 2018, 02:59 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Schobel Alexander MarkChief Innovation/Tech Officer03/15/2024300,000
Barber DanielPresident and CEO03/09/2024185,137
Boyd Peter E.See Remark03/09/202440,846
BRAENDER LORI JSVP, General Counsel03/09/202451,386
TOTH A ERNEST JRSVP, Chief Financial Officer03/09/202457,120
Wargacki StephenSVP, Research & Development03/10/20248,233
Wargacki StephenSVP, Research & Development03/09/202454,993
Jung CassieSVP, Operations03/10/20245,524
Jung CassieSVP, Operations03/09/202440,504
Schobel Alexander MarkChief Innovation/Tech Officer03/09/202428,768
Schobel Alexander MarkChief Innovation/Tech Officer03/08/2024129,685
Wargacki StephenSVP, Research & Development03/10/20231,572
Boyd Peter E.SVP-Bus. Process & Info. Tech.06/14/20224,050
Barber DanielChief Executive Officer06/08/202288,073
Schobel Alexander MarkChief Innovation/Tech Officer06/08/202244,036
Boyd Peter E.SVP-Bus. Process & Info. Tech.06/08/20222,201
BRAENDER LORI JGeneral Counsel06/08/202213,211
Schobel Alexander MarkChief Innovation/Tech Officer02/10/2021158,355
Schobel Alexander MarkChief Innovation/Tech Officer02/09/202177,895
Schobel Alexander MarkChief Innovation/Tech Officer02/08/2021265,148
Maxwell John T.SVP-Chief Financial Officer08/18/202024,000
Kendall Keith JCEO and President06/30/2020719
Schobel Alexander MarkChief Innovation/Tech Officer06/30/2020457
Kendall Keith JCEO and President06/04/2020255,310
Schobel Alexander MarkChief Innovation/Tech Officer05/31/202020,123
Kendall Keith JCEO and President05/31/202031,616
Schobel Alexander MarkChief Innovation/Tech Officer05/08/2020200,000
Schobel Alexander MarkChief Innovation/Tech Officer04/27/2020160,000
Schobel Alexander MarkChief Innovation/Tech Officer04/14/2020148,000
Schobel Alexander MarkChief Innovation/Tech Officer04/29/2020180,000
Kendall Keith JCEO and President03/31/2020217
Schobel Alexander MarkChief Innovation/Tech Officer03/31/2020212
BRAENDER LORI JSVP, General Counsel03/16/202021,624
Boyd Peter E.SVP-Bus. Process & Info. Tech.03/16/20203,000
Schobel Alexander MarkChief Innovation/Tech Officer02/29/202018,896
Kendall Keith JCEO and President02/29/202017,639
Kendall Keith JCEO and President12/31/2019867
Schobel Alexander MarkChief Innovation/Tech Officer12/31/2019856
Kendall Keith JCEO and President11/30/201951,391
Schobel Alexander MarkChief Innovation/Tech Officer11/30/201950,978
Schobel Alexander MarkChief Innovation/Tech Officer12/31/20191,915
Kendall Keith JCEO and President12/31/20191,915
Kendall Keith JCEO and President11/30/2019113,516
Schobel Alexander MarkChief Innovation/Tech Officer11/30/2019113,516
Schobel Alexander MarkChief Innovation/Tech Officer09/30/2019461
Kendall Keith JCEO and President09/30/2019477
Kendall Keith JCEO and President08/31/201925,369
Schobel Alexander MarkChief Innovation/Tech Officer08/31/201924,548
Barber DanielSVP-Chief Operating Officer08/27/20197,980
Scibetta James SDirector08/21/20193,429
Scibetta James SDirector08/20/201943,001
Scibetta James SDirector08/19/201940,547
Kendall Keith JCEO and President08/14/20197,347
Kendall Keith JCEO and President08/13/20194,045
Kendall Keith JCEO and President08/09/201919,595
Wood TheresaSVP-HR and Org. Development08/09/20193,990
BRAENDER LORI JSVP, General Counsel08/09/201940,747
Boyd Peter E.SVP-Bus. Process & Info. Tech.08/12/20192,286
Kendall Keith JCEO and President06/30/2019647
Schobel Alexander MarkChief Innovation/Tech Officer06/30/2019626
Schobel Alexander MarkChief Innovation/Tech Officer05/31/201924,519
Kendall Keith JCEO and President05/31/201925,222
Schobel Alexander MarkChief Innovation/Tech Officer03/31/20191,817
Kendall Keith JCEO and President03/31/20191,817
Kendall Keith JCEO and President02/28/201938,036
Schobel Alexander MarkChief Innovation/Tech Officer02/28/201954,104
Schobel Alexander MarkChief Innovation/Tech Officer12/31/20181,021
Kendall Keith JCEO and President12/31/20181,021
Schobel Alexander MarkChief Innovation/Tech Officer12/10/20187,780
Schobel Alexander MarkChief Innovation/Tech Officer12/06/201817,380
Barber DanielSVP-Chief Strategy/Dev Officer12/10/20188,000
Maxwell John T.SVP-Chief Financial Officer12/06/201844,350
Schobel Alexander MarkChief Innovation/Tech Officer11/30/201861,650
Kendall Keith JCEO and President11/30/201861,650
Marshall Ken W.Commercial Leader11/21/201814,667
BRAENDER LORI JGeneral Counsel11/27/201810,570
Kendall Keith JCEO and President11/27/20189,870
Wood TheresaSVP-HR and Org. Development11/26/20185,170
Schobel Alexander MarkChief Innovation/Tech Officer11/21/201810,250
Maxwell John T.SVP-Chief Financial Officer11/21/201898,000
Kendall Keith JCEO and President11/23/201819,305
Kendall Keith JCEO and President11/21/201861,020
Boyd Peter E.SVP-Operations/Value Delivery11/21/20181,996
Kendall Keith JCEO and President09/30/20182,837
Schobel Alexander MarkChief Innovation/Tech Officer09/30/20182,837
Kendall Keith JCEO and President08/31/2018117,245
Schobel Alexander MarkChief Innovation/Tech Officer08/31/2018117,245
BRATTON DOUGLAS KDirector07/24/20182,475,000
Load More Insider Transactions
FUNDS WITH A POSITION IN AQUESTIVE THERAPEUTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
RENAISSANCE TECHNOLOGIES LLC1,271,5000.00397%12.6%Other
GEODE CAPITAL MANAGEMENT, LLC494,9020.0001%8.4%Other
BLACKROCK INC.478,0190.00002%-0.41%Other
CHANGE IN SHARES OUTSTANDING FOR AQUESTIVE THERAPEUTICS INC
STOCK BUYBACKS FOR AQUESTIVE THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
-6.49%
1Q
12/31/2023
06/30/2023
5.46%
2Q
12/31/2023
03/31/2023
-18.04%
3Q
12/31/2023
12/31/2022
11.07%
4Q
12/31/2023
09/30/2022
13.21%
5Q
12/31/2023
06/30/2022
33.04%
6Q
12/31/2023
03/31/2022
45.86%
7Q
12/31/2023
12/31/2021
49.65%
8Q
12/31/2023
09/30/2021
54.19%
9Q
12/31/2023
06/30/2021
63.18%
10Q
12/31/2023
03/31/2021
70.07%
11Q
12/31/2023
12/31/2020
78.80%
12Q
12/31/2023
09/30/2020
79.90%
13Q
12/31/2023
06/30/2020
80.06%
14Q
12/31/2023
03/31/2020
80.17%
15Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
-6.49%
1Q
06/30/2023
5.46%
2Q
03/31/2023
-18.04%
3Q
12/31/2022
11.07%
4Q
09/30/2022
13.21%
5Q
06/30/2022
33.04%
6Q
03/31/2022
45.86%
7Q
12/31/2021
49.65%
8Q
09/30/2021
54.19%
9Q
06/30/2021
63.18%
10Q
03/31/2021
70.07%
11Q
12/31/2020
78.80%
12Q
09/30/2020
79.90%
13Q
06/30/2020
80.06%
14Q
03/31/2020
80.17%
15Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR AQUESTIVE THERAPEUTICS INC
LOADING...